Literature DB >> 17136329

Viral vectors as a tool to model and treat Parkinson's disease.

Jean-Charles Bensadoun1, Patrick Aebischer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17136329     DOI： 10.1007/s00508-006-0736-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  8 in total

1.  Lentiviral gene transfer to the nonhuman primate brain.

Authors:  J H Kordower; J Bloch; S Y Ma; Y Chu; S Palfi; B Z Roitberg; M Emborg; P Hantraye; N Déglon; P Aebischer
Journal:  Exp Neurol       Date:  1999-11       Impact factor: 5.330

2.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Authors:  J H Kordower; M E Emborg; J Bloch; S Y Ma; Y Chu; L Leventhal; J McBride; E Y Chen; S Palfi; B Z Roitberg; W D Brown; J E Holden; R Pyzalski; M D Taylor; P Carvey; Z Ling; D Trono; P Hantraye; N Déglon; P Aebischer
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

3.  Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease.

Authors:  N Déglon; J L Tseng; J C Bensadoun; A D Zurn; Y Arsenijevic; L Pereira de Almeida; R Zufferey; D Trono; P Aebischer
Journal:  Hum Gene Ther       Date:  2000-01-01       Impact factor: 5.695

4.  Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

Authors:  J C Bensadoun; N Déglon; J L Tseng; J L Ridet; A D Zurn; P Aebischer
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

5.  Lentivirus-mediated expression of glutathione peroxidase: neuroprotection in murine models of Parkinson's disease.

Authors:  Jean-Luc Ridet; Jean-Charles Bensadoun; Nicole Déglon; Patrick Aebischer; Anne D Zurn
Journal:  Neurobiol Dis       Date:  2005-07-14       Impact factor: 5.996

6.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Authors:  Christophe Lo Bianco; Bernard L Schneider; Matthias Bauer; Ali Sajadi; Alexis Brice; Takeshi Iwatsubo; Patrick Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

7.  alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

Authors:  C Lo Bianco; J-L Ridet; B L Schneider; N Deglon; P Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

8.  Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease.

Authors:  C Lo Bianco; N Déglon; W Pralong; P Aebischer
Journal:  Neurobiol Dis       Date:  2004-11       Impact factor: 5.996
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.